Of the $715 billion global impact investing market, corporate impact investors in innovation manage more than $7.2 billion in committed capital, an amount that has been increasing at a 54% compounded annual rate since 2016, according to this Stanford Social Innovation Review article. However, only 7% of the total impact investing assets under management focus on improving health, not nearly the capital needed to solve the many critical public health challenges facing our world today. Impact investors not engaged in global health have cited the unique and high risks in health innovation (that an investment may not provide returns quickly or at all) and the specific expertise required to help health start-ups scale and maximize impact.
